Q322 sees a tidal wave of new robotic spine surgery competitors as well as data-driven initiatives under development by a host of companies in the market for spine enabling tech.
Q322 was nothing short of a tidal wave of competitive entrants to the US Spine Robotic Surgery space. Medtronic* (MDT) and Globus* remain top players as OUS companies like France’s eCential Robotics* and Taiwan’s Point Robotics MedTech* set their sights on the US market. The Q322 WW CAS Spine Market was up, according to SmartTRAK Financial Dashboard. MDT remained the market leader with 49.0% share, followed by Globus and other enabling tech competitors like Brainlab* and Stryker* (SYK).Among the many topics covered in detail in our comprehensive Q322 CAS Spine Market Recap* are: